Premier acquires clinical surveillance software provider for $117m

By Zachary Brennan

- Last updated on GMT

The company was originally acquired by Hospira in 2009 for $63m
The company was originally acquired by Hospira in 2009 for $63m

Related tags Health care

Healthcare company Premier has purchased Hospira subsidiary TheraDoc, a provider of electronic clinical surveillance, for $117m (€87.5m).

The acquisition builds on Premier’s real-time surveillance and outcomes management while adding  about 400 unaffiliated facilities to its footprint. TheraDoc’s offices in Salt Lake City and its 120 employees will become part of Premier’s Performance Services business unit, reporting to Keith J. Figlioli, Premier’s SVP of Healthcare Informatics.

Acquired by Hospira in 2009 for $63m in cash, TheraDoc provides data analytics and informatics to healthcare organizations and is currently installed in about 600 US facilities, according to Citi Research analyst Garen Sarafian, who expressed positive support for the deal. TheraDoc’s products range from clinical intelligence -- offering alerts to physicians regarding patient statuses -- to using clinical data to identify healthcare-associated infections.

France Pitera, who is currently VP of Hospira, and is planned to be named VP of Safety Solutions at Premier, noted: “Considering that only 50 percent of providers have invested in electronic clinical surveillance, our increased scope already addresses a largely untapped marketplace with an unmatched, best-in-class solution. We will leverage the collective resources of TheraDoc and deep analytics capabilities available through the PremierConnect platform to continue developing a broad suite of quality and safety products in a cutting-edge SaaS [software as a service] model​.”

The acquisition provides Premier access to TheraDoc’s long-standing relationships, which should provide cross-selling opportunities for Premier, according to Sarafian, who added that this is “consistent with the firm’s post-IPO strategy to expand its footprint beyond its current member base​.”

Combined, the two organizations will provide clinical surveillance expertise to about 1,000 facilities. TheraDoc was ranked by KLAS, a health informatics research company, as the top product in the infection control and monitoring software category in both 2012 and 2013. 

With the addition of 400 facilities to its footprint, combined with the market for electronic clinical surveillance which, according to HIMSS, “remains attractive and unsaturated, Premier is now well positioned to capitalize on this growth opportunity​,” Sarafian added.

Related news

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more